News
Stay up to date on the latest crypto trends with our expert, in-depth coverage.


Shiba Inu (SHIB) Climbs 5% Despite Death Cross Signal
TimesTabloid·2026/03/25 00:12

Renminbi: A New Normal of Enhanced Flexibility and Unwavering Resilience
早安汇市·2026/03/25 00:05
BOJ: Summary of the Monetary Policy Meeting Held on January 22-23, 2026
101 finance·2026/03/24 23:54
USD/CHF Price Forecast: Bulls clash at 100-day SMA, eyes on 0.7950
101 finance·2026/03/24 23:21

Rising US treasury yields, war in Iran, rising inflation risk pressure Bitcoin price
Cointelegraph·2026/03/24 23:15
AUD/USD hovers close to 0.7000 as markets await crucial CPI release
101 finance·2026/03/24 23:13
Flash
21:14
Data released by Westpac Bank shows that New Zealand's Consumer Confidence Index fell to 80.4 in the second quarter, marking the lowest level in three years.The decline in the index also reflects that local residents remain cautious about the current economic environment and expectations regarding household income and expenditures. The recovery of consumer confidence will likely continue to depend on multiple fundamental factors such as a stable job market and easing inflation.
20:57
US Dollar Index Falls 0.09% on 16th The US Dollar Index fell 0.09% on the 16th, closing at 99.540 in the foreign exchange market.
20:48
According to a document submitted to the U.S. Securities and Exchange Commission, an agreement between Arvinas Holding Company LLC and Pfizer indicates that both parties are eligible for milestone payments totaling up to 320 millions USD, along with a tiered royalty structure.The document further clarifies the conditions and specific terms that trigger payment. Milestone payments will be distributed in phases based on the progress of R&D in the collaborative project, regulatory approvals, and commercialization outcomes at different stages. Tiered royalties mean that as product sales reach different thresholds, the rates will be adjusted accordingly, providing both parties with a more flexible revenue-sharing mechanism. This financial arrangement highlights both parties' confidence in the project's prospects and reflects the risk-sharing and profit-sharing models commonly seen in the biopharmaceutical industry. Although the details of the agreement have not been fully disclosed, the total potential revenue of up to $320 million undoubtedly injects strong financial momentum into the subsequent development of the project.
News